IL115754A - Liposomic composition containing selegilin and process for its preparation - Google Patents

Liposomic composition containing selegilin and process for its preparation

Info

Publication number
IL115754A
IL115754A IL11575495A IL11575495A IL115754A IL 115754 A IL115754 A IL 115754A IL 11575495 A IL11575495 A IL 11575495A IL 11575495 A IL11575495 A IL 11575495A IL 115754 A IL115754 A IL 115754A
Authority
IL
Israel
Prior art keywords
weight
liposomic
pct
selegilin
composition
Prior art date
Application number
IL11575495A
Other languages
English (en)
Other versions
IL115754A0 (en
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of IL115754A0 publication Critical patent/IL115754A0/xx
Publication of IL115754A publication Critical patent/IL115754A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Dental Preparations (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL11575495A 1994-10-24 1995-10-24 Liposomic composition containing selegilin and process for its preparation IL115754A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9403073A HU223475B1 (hu) 1994-10-24 1994-10-24 Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására

Publications (2)

Publication Number Publication Date
IL115754A0 IL115754A0 (en) 1996-01-19
IL115754A true IL115754A (en) 1999-07-14

Family

ID=10985697

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11575495A IL115754A (en) 1994-10-24 1995-10-24 Liposomic composition containing selegilin and process for its preparation

Country Status (30)

Country Link
US (1) US5888536A (pl)
EP (1) EP0788349B1 (pl)
JP (1) JPH10507749A (pl)
KR (1) KR100313149B1 (pl)
CN (1) CN1084186C (pl)
AT (1) ATE205387T1 (pl)
AU (1) AU691348B2 (pl)
BG (1) BG63327B1 (pl)
BR (1) BR9509517A (pl)
CA (1) CA2203513C (pl)
CZ (1) CZ287349B6 (pl)
DE (1) DE69522701T2 (pl)
DK (1) DK0788349T3 (pl)
EE (1) EE03418B1 (pl)
ES (1) ES2160718T3 (pl)
FI (1) FI971743A0 (pl)
HU (1) HU223475B1 (pl)
IL (1) IL115754A (pl)
NO (1) NO316354B1 (pl)
NZ (1) NZ294660A (pl)
PL (1) PL183104B1 (pl)
PT (1) PT788349E (pl)
RO (1) RO116768B1 (pl)
RU (1) RU2159106C2 (pl)
SK (1) SK281599B6 (pl)
TW (1) TW412420B (pl)
UA (1) UA44289C2 (pl)
WO (1) WO1996012472A1 (pl)
YU (1) YU49313B (pl)
ZA (1) ZA958999B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999037293A2 (en) * 1998-01-27 1999-07-29 Thomas Thomas N Use of an mao-a or mao-b inhibitor for the treatment of vascular disorders
DE19814257A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
GB9815785D0 (en) * 1998-07-20 1998-09-16 Cerebrus Ltd Chemical compounds
CN102293746A (zh) * 2003-09-09 2011-12-28 吉里德科学公司 治疗性脂质体
US20080233053A1 (en) * 2005-02-07 2008-09-25 Pharmalight Inc. Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
CN1813679A (zh) * 2005-11-30 2006-08-09 上海医药(集团)有限公司 一种紫杉烷脂质体冻干组合物及其制备方法
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
JP5623102B2 (ja) * 2010-03-12 2014-11-12 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
JP5693026B2 (ja) * 2010-03-12 2015-04-01 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
CN104427976B (zh) 2012-05-10 2018-04-24 佩因拉佛姆有限公司 疏水的活性成分的储库制剂及其制备方法
WO2016051424A1 (en) * 2014-09-29 2016-04-07 Council Of Scientific & Industrial Research A formulation useful for delivery of neuro protecting agent
LT3600435T (lt) * 2017-03-23 2024-04-25 Lipid Systems Sp. Z.O.O. Hidrofilinių junginių aukšto efektyvumo įkapsuliavimas vienasluoksnėse liposomose

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588887A5 (pl) * 1974-07-19 1977-06-15 Battelle Memorial Institute
US4485054A (en) * 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4761288A (en) * 1984-09-24 1988-08-02 Mezei Associates Limited Multiphase liposomal drug delivery system
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
US4937078A (en) * 1988-08-26 1990-06-26 Mezei Associates Limited Liposomal local anesthetic and analgesic products
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
HU209605B (en) * 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
FR2713087B1 (fr) * 1993-11-30 1996-02-23 Saurat Jean Hilaire Utilisation de la sélégiline et ses dérivés pour la préparation d'un médicament destiné au traitement du psoriasis.

Also Published As

Publication number Publication date
BR9509517A (pt) 1997-12-30
FI971743A7 (fi) 1997-04-23
UA44289C2 (uk) 2002-02-15
KR970706797A (ko) 1997-12-01
RU2159106C2 (ru) 2000-11-20
CN1084186C (zh) 2002-05-08
NO971870L (no) 1997-06-24
JPH10507749A (ja) 1998-07-28
SK281599B6 (sk) 2001-05-10
ZA958999B (en) 1996-05-15
FI971743L (fi) 1997-04-23
ES2160718T3 (es) 2001-11-16
AU691348B2 (en) 1998-05-14
EE03418B1 (et) 2001-06-15
HUT76053A (en) 1997-06-30
KR100313149B1 (ko) 2002-02-19
PL319875A1 (en) 1997-09-01
NZ294660A (en) 1998-05-27
IL115754A0 (en) 1996-01-19
EP0788349B1 (en) 2001-09-12
DE69522701D1 (de) 2001-10-18
CZ114797A3 (en) 1997-10-15
NO971870D0 (no) 1997-04-23
SK51797A3 (en) 1997-11-05
YU67195A (sh) 1998-07-10
CA2203513C (en) 2001-10-09
US5888536A (en) 1999-03-30
CA2203513A1 (en) 1996-05-02
EE9700102A (et) 1997-10-15
ATE205387T1 (de) 2001-09-15
DK0788349T3 (da) 2001-11-26
RO116768B1 (ro) 2001-06-29
NO316354B1 (no) 2004-01-19
DE69522701T2 (de) 2002-07-11
FI971743A0 (fi) 1997-04-23
PL183104B1 (pl) 2002-05-31
EP0788349A1 (en) 1997-08-13
WO1996012472A1 (en) 1996-05-02
YU49313B (sh) 2005-06-10
HU9403073D0 (en) 1994-12-28
MX9703019A (es) 1997-10-31
BG63327B1 (bg) 2001-10-31
BG101432A (bg) 1997-12-30
CN1163563A (zh) 1997-10-29
PT788349E (pt) 2001-12-28
CZ287349B6 (en) 2000-10-11
HU223475B1 (hu) 2004-07-28
AU3751895A (en) 1996-05-15
TW412420B (en) 2000-11-21

Similar Documents

Publication Publication Date Title
GR3036772T3 (en) Topically applied pharmaceutical composition, method of preparing it and its use
JP2002003364A (ja) 点眼剤、眼科用組成物及び吸着抑制方法
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
ZA958999B (en) Liposomic composition
JP3142842B1 (ja) 眼科用組成物及びソフトコンタクトレンズへの吸着抑制方法
JP5616620B2 (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP2023090938A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤
JP3175742B1 (ja) コンタクトレンズ用眼科用組成物
MXPA04005558A (es) Composiciones farmaceuticas a base de derivados de azetidina.
JP2001253822A (ja) 角膜細胞回復剤組成物
JP3734521B2 (ja) 点眼製剤
GB2100599A (en) Pharmaceutical preparation for treating glaucoma and ocular hypertension
JP2002104971A (ja) 眼科用組成物
TW200733897A (en) Oral product for moistening skin
JP2005075735A (ja) オキシメタゾリン含有組成物
JP2001187741A (ja) 皮膚外用医薬組成物
JP2024006961A (ja) オートファジー活性化剤及びオートファジー活性低下抑制方法
JPH11180872A (ja) 骨代謝改善剤
JP2015098473A (ja) シリコーンハイドロゲルコンタクトレンズ用眼科組成物

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees